Research Article
Cystatin C at Admission in the Intensive Care Unit Predicts Mortality among Elderly Patients
Table 3
Logistic regression analysis of mortality according to cystatin C > 0.96 mg/L.
| Outcome | HR | 95% CI | P value |
| Mortality | | | | Unadjusted | 6.11 | 1.66–22.5 | 0.007 | Adjusted for age and gender | 5.54 | 1.45–21.12 | 0.01 | Adjusted for age, gender, and APACHE II score | 5.35 | 1.39–20.51 | 0.01 | Adjusted for age, gender, APACHE II score, and vasopressors
| 5.48 | 1.40–21.44 | 0.01 | Adjusted for age, gender, APACHE II, vasopressors, and sepsis
| 5.00 | 1.26–20.11 | 0.02 | Adjusted for age, gender APACHE II, vasopressors, sepsis, and ICU hospitalization
| 5.63 | 1.38–22.96 | 0.02 | Adjusted for age, gender APACHE II, vasopressors, sepsis, ICU hospitalization, and albumin | 6.16 | 1.46–26.00 | 0.01 |
|
|
HR: hazard ratio, ICU: intensive care unit.
|